Oxime-assisted acetylcholinesterase catalytic scavengers of organophosphates that resist aging

Rory Cochran, Jarosław Kalisiak, Tuba Küçükkilinç, Zoran Radić, Edzna Garcia, Limin Zhang, Kwok Yiu Ho, Gabriel Amitai, Zrinka Kovarik, Valery V. Fokin, K. Barry Sharpless, Palmer Taylor

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

The cholinesterases, acetylcholinesterase (AChE) and butyrylcholinesterase, are primary targets of organophosphates (OPs). Exposure to OPs can lead to serious cardiovascular complications, respiratory compromise, and death. Current therapy to combat OP poisoning involves an oxime reactivator (2-PAM, obidoxime, TMB4, or HI-6) combined with atropine and on occasion an anticonvulsant. Butyrylcholinesterase, administered in the plasma compartment as a bio-scavenger, has also shown efficacy but is limited by its strict stoichiometric scavenging, slow reactivation, and a propensity for aging. Here, we characterize 10 human (h) AChE mutants that, when coupled with an oxime, give rise to catalytic reactivation and aging resistance of the soman conjugate. With the most efficient human AChE mutant Y337A/F338A, we show enhanced reactivation rates for several OP-hAChE conjugates compared with wild-type hAChE when reactivated with HI-6 (1-(2′-hydroxyiminomethyl-1′- pyridinium)-3-(4′-carbamoyl-1-pyridinium)). In addition, we interrogated an 840-member novel oxime library for reactivation of Y337A/F338A hAChE-OP conjugates to delineate the most efficient oxime-mutant enzyme pairs for catalytic bioscavenging. Combining the increased accessibility of the Y337A mutation to oximes within the space-impacted active center gorge with the aging resistance of the F338A mutation provides increased substrate diversity in scavenging potential for agingprone alkyl phosphate inhibitors.

Original languageEnglish
Pages (from-to)29718-29724
Number of pages7
JournalJournal of Biological Chemistry
Volume286
Issue number34
DOIs
Publication statusPublished - 26 Aug 2011
Externally publishedYes

Fingerprint

Oximes
Organophosphates
Acetylcholinesterase
Aging of materials
Butyrylcholinesterase
Scavenging
Obidoxime Chloride
Soman
Organophosphate Poisoning
Mutation
Cholinesterases
Atropine
Anticonvulsants
Phosphates
Plasmas
Substrates
Enzymes

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Cochran, R., Kalisiak, J., Küçükkilinç, T., Radić, Z., Garcia, E., Zhang, L., ... Taylor, P. (2011). Oxime-assisted acetylcholinesterase catalytic scavengers of organophosphates that resist aging. Journal of Biological Chemistry, 286(34), 29718-29724. https://doi.org/10.1074/jbc.M111.264739

Oxime-assisted acetylcholinesterase catalytic scavengers of organophosphates that resist aging. / Cochran, Rory; Kalisiak, Jarosław; Küçükkilinç, Tuba; Radić, Zoran; Garcia, Edzna; Zhang, Limin; Ho, Kwok Yiu; Amitai, Gabriel; Kovarik, Zrinka; Fokin, Valery V.; Sharpless, K. Barry; Taylor, Palmer.

In: Journal of Biological Chemistry, Vol. 286, No. 34, 26.08.2011, p. 29718-29724.

Research output: Contribution to journalArticle

Cochran, R, Kalisiak, J, Küçükkilinç, T, Radić, Z, Garcia, E, Zhang, L, Ho, KY, Amitai, G, Kovarik, Z, Fokin, VV, Sharpless, KB & Taylor, P 2011, 'Oxime-assisted acetylcholinesterase catalytic scavengers of organophosphates that resist aging', Journal of Biological Chemistry, vol. 286, no. 34, pp. 29718-29724. https://doi.org/10.1074/jbc.M111.264739
Cochran R, Kalisiak J, Küçükkilinç T, Radić Z, Garcia E, Zhang L et al. Oxime-assisted acetylcholinesterase catalytic scavengers of organophosphates that resist aging. Journal of Biological Chemistry. 2011 Aug 26;286(34):29718-29724. https://doi.org/10.1074/jbc.M111.264739
Cochran, Rory ; Kalisiak, Jarosław ; Küçükkilinç, Tuba ; Radić, Zoran ; Garcia, Edzna ; Zhang, Limin ; Ho, Kwok Yiu ; Amitai, Gabriel ; Kovarik, Zrinka ; Fokin, Valery V. ; Sharpless, K. Barry ; Taylor, Palmer. / Oxime-assisted acetylcholinesterase catalytic scavengers of organophosphates that resist aging. In: Journal of Biological Chemistry. 2011 ; Vol. 286, No. 34. pp. 29718-29724.
@article{93a476987ac5458c9e9e8ed726654d2a,
title = "Oxime-assisted acetylcholinesterase catalytic scavengers of organophosphates that resist aging",
abstract = "The cholinesterases, acetylcholinesterase (AChE) and butyrylcholinesterase, are primary targets of organophosphates (OPs). Exposure to OPs can lead to serious cardiovascular complications, respiratory compromise, and death. Current therapy to combat OP poisoning involves an oxime reactivator (2-PAM, obidoxime, TMB4, or HI-6) combined with atropine and on occasion an anticonvulsant. Butyrylcholinesterase, administered in the plasma compartment as a bio-scavenger, has also shown efficacy but is limited by its strict stoichiometric scavenging, slow reactivation, and a propensity for aging. Here, we characterize 10 human (h) AChE mutants that, when coupled with an oxime, give rise to catalytic reactivation and aging resistance of the soman conjugate. With the most efficient human AChE mutant Y337A/F338A, we show enhanced reactivation rates for several OP-hAChE conjugates compared with wild-type hAChE when reactivated with HI-6 (1-(2′-hydroxyiminomethyl-1′- pyridinium)-3-(4′-carbamoyl-1-pyridinium)). In addition, we interrogated an 840-member novel oxime library for reactivation of Y337A/F338A hAChE-OP conjugates to delineate the most efficient oxime-mutant enzyme pairs for catalytic bioscavenging. Combining the increased accessibility of the Y337A mutation to oximes within the space-impacted active center gorge with the aging resistance of the F338A mutation provides increased substrate diversity in scavenging potential for agingprone alkyl phosphate inhibitors.",
author = "Rory Cochran and Jarosław Kalisiak and Tuba K{\"u}{\cc}{\"u}kkilin{\cc} and Zoran Radić and Edzna Garcia and Limin Zhang and Ho, {Kwok Yiu} and Gabriel Amitai and Zrinka Kovarik and Fokin, {Valery V.} and Sharpless, {K. Barry} and Palmer Taylor",
year = "2011",
month = "8",
day = "26",
doi = "10.1074/jbc.M111.264739",
language = "English",
volume = "286",
pages = "29718--29724",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "34",

}

TY - JOUR

T1 - Oxime-assisted acetylcholinesterase catalytic scavengers of organophosphates that resist aging

AU - Cochran, Rory

AU - Kalisiak, Jarosław

AU - Küçükkilinç, Tuba

AU - Radić, Zoran

AU - Garcia, Edzna

AU - Zhang, Limin

AU - Ho, Kwok Yiu

AU - Amitai, Gabriel

AU - Kovarik, Zrinka

AU - Fokin, Valery V.

AU - Sharpless, K. Barry

AU - Taylor, Palmer

PY - 2011/8/26

Y1 - 2011/8/26

N2 - The cholinesterases, acetylcholinesterase (AChE) and butyrylcholinesterase, are primary targets of organophosphates (OPs). Exposure to OPs can lead to serious cardiovascular complications, respiratory compromise, and death. Current therapy to combat OP poisoning involves an oxime reactivator (2-PAM, obidoxime, TMB4, or HI-6) combined with atropine and on occasion an anticonvulsant. Butyrylcholinesterase, administered in the plasma compartment as a bio-scavenger, has also shown efficacy but is limited by its strict stoichiometric scavenging, slow reactivation, and a propensity for aging. Here, we characterize 10 human (h) AChE mutants that, when coupled with an oxime, give rise to catalytic reactivation and aging resistance of the soman conjugate. With the most efficient human AChE mutant Y337A/F338A, we show enhanced reactivation rates for several OP-hAChE conjugates compared with wild-type hAChE when reactivated with HI-6 (1-(2′-hydroxyiminomethyl-1′- pyridinium)-3-(4′-carbamoyl-1-pyridinium)). In addition, we interrogated an 840-member novel oxime library for reactivation of Y337A/F338A hAChE-OP conjugates to delineate the most efficient oxime-mutant enzyme pairs for catalytic bioscavenging. Combining the increased accessibility of the Y337A mutation to oximes within the space-impacted active center gorge with the aging resistance of the F338A mutation provides increased substrate diversity in scavenging potential for agingprone alkyl phosphate inhibitors.

AB - The cholinesterases, acetylcholinesterase (AChE) and butyrylcholinesterase, are primary targets of organophosphates (OPs). Exposure to OPs can lead to serious cardiovascular complications, respiratory compromise, and death. Current therapy to combat OP poisoning involves an oxime reactivator (2-PAM, obidoxime, TMB4, or HI-6) combined with atropine and on occasion an anticonvulsant. Butyrylcholinesterase, administered in the plasma compartment as a bio-scavenger, has also shown efficacy but is limited by its strict stoichiometric scavenging, slow reactivation, and a propensity for aging. Here, we characterize 10 human (h) AChE mutants that, when coupled with an oxime, give rise to catalytic reactivation and aging resistance of the soman conjugate. With the most efficient human AChE mutant Y337A/F338A, we show enhanced reactivation rates for several OP-hAChE conjugates compared with wild-type hAChE when reactivated with HI-6 (1-(2′-hydroxyiminomethyl-1′- pyridinium)-3-(4′-carbamoyl-1-pyridinium)). In addition, we interrogated an 840-member novel oxime library for reactivation of Y337A/F338A hAChE-OP conjugates to delineate the most efficient oxime-mutant enzyme pairs for catalytic bioscavenging. Combining the increased accessibility of the Y337A mutation to oximes within the space-impacted active center gorge with the aging resistance of the F338A mutation provides increased substrate diversity in scavenging potential for agingprone alkyl phosphate inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=80051922044&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051922044&partnerID=8YFLogxK

U2 - 10.1074/jbc.M111.264739

DO - 10.1074/jbc.M111.264739

M3 - Article

C2 - 21730071

AN - SCOPUS:80051922044

VL - 286

SP - 29718

EP - 29724

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 34

ER -